Table 3.
Differentially expressed genes in fetal intestine by maternal high fat intake and validated by qPCR
Fold changeb | |||
---|---|---|---|
Gene symbola | cDNA Microarray | qPCR | P value |
ACTA2 | 1.66 | 1.10 | 0.246 |
SULT1E1 | 2.59 | 1.88 | 0.002 |
SOD2 | 1.51 | 1.75 | 0.036 |
BMP7 | −1.59 | −1.09 | 0.722 |
CD40 | −2.00 | −1.74 | 0.116 |
CD74 | −1.49 | −1.36 | 0.029 |
CD8A | −2.44 | −1.85 | 0.049 |
GK | −1.64 | −1.33 | 0.041 |
HSPAIL | −2.50 | −1.60 | 0.027 |
PIK3R5 | −1.56 | −1.07 | 0.644 |
PSTPIP1 | −1.85 | −1.48 | 0.083 |
SLA-1 | −1.49 | −1.45 | 0.097 |
SLA-DQA1 | −1.85 | −1.79 | 0.003 |
SLA-DRB1 | −1.52 | −1.33 | 0.136 |
STAT2 | −1.69 | −1.18 | 0.125 |
TGF-β | −1.52 | −1.19 | 0.296 |
THY1 | −1.52 | −1.29 | 0.118 |
aGenes were selected on the basis of their crucial role on regulating intestinal immune response (i.e.SLA-DRB1,SLA-DQA,HSPA1L,CD74,CD40), colorectal cancer (i.e.TGF-β,PIK3R5), signal transduction (i.e. PSTPIP1,BMP7,STAT2) and metabolism (i.e.GK, SULT1E1). These genes by DNA microarray were all significantly regulated (P < 0.05, at least 1.5 fold change)
bThe fold change was based on the ratio of HF group to CON group, n = 4 subpools/group